Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with parkinson's disease

Movement Disorders

Volumn 18, Issue 6, 2003, Pages 712-713

  Prueter, Christian ^a   Habermeyer, Benedikt ^a   Norra, Christine ^a   Kosinski, Christoph M ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Akathisia; Dopamimetic psychosis; Quetiapine

Indexed keywords

AMANTADINE; CLOZAPINE; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE;

ADULT; AKATHISIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; SCORING SYSTEM;

AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 0038422125     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10419     Document Type: Article

References (14)

1. Parsa MA, Bastani B. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 1998;10:216-219.
2. Menza MMA, Palermo B, Mark M. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease. Ann Clin Psychiatry 1999;11:141-144.
3. Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 2000;15:201-211.
4. Matheson AJ, Lamb HM. Quetiapine - a review of its clinical potential in the management of psychotic symptoms in Parkinson's disease. CNS Drugs 2000;14:157-172.
5. Weiner WJ, Minagar A, Shulman LM. Quetiapine for L-dopa-induced psychosis in PD. Neurology 2000;54:1538.
6. Goldstein JM. The new generation of antipsychotic drugs: how atypical are they? Int J Neuropsychopharmacol 2000;3:339-349.
7. Sommer BR. Quetiapine-induced extrapyramidal side effects in patients with Parkinson's disease: case report. J Geriatr Psychiatry Neurol 2001;14:99-100.
8. Barnes TRE. A rating scale for drug induced akathisia. Br J Psychiatry 1989;154:672-676.
9. Musser WS, Akil M. Clozapine as a treatment of psychosis in Parkinson's disease: a review. J Neuropsychiatry Clin Neurosci 1996;8:1-9.
10. Small JG, Hirsch SR, Arvantis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia. A high- and low-dose double blind comparison with placebo. Seroquel study group. Arch Gen Psychiatry 1997;54:549-557.
11. Yeung PP, Tariot PN, Schneider LS, et al. Quetiapine for elderly patients with psychotic disorders. Psychiatr Ann 2000;30:197-201.
12. Ghelber D, Belmaker RH. Tardive dyskinesia with quetiapine. Am J Psychiatry 1999;156:796-797.
13. Ghaemi SN, Ko JY. Quetiapine-related tardive dyskinesia. Am J Psychiatry 2001;158:1737.
14. Gelder M, Gath D, Mayou R, Cowen P. Oxford textbook of psychiatry, 3rd ed. Oxford: Oxford University, 1996. p 510-531.